ICAD vs. PHIO

Last updated Jun 3, 2026

ICAD (iCAD, Inc.) and PHIO (Phio Pharmaceuticals Corp.) are both stocks. Both are in the Healthcare sector — ICAD in Health Information Services, PHIO in Biotechnology. At a 0.12 correlation, their price movements are largely independent.

Performance

ICAD vs. PHIO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iCAD, Inc. (ICAD) and Phio Pharmaceuticals Corp. (PHIO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ICAD

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

PHIO

• 1D: -0.88%
• 1M: -1.75%
• YTD: 6.67%
• 6M: -8.94%
• 1Y: -45.37%
• 3Y*: -66.60%
• 5Y*: -65.65%
• 10Y*: -68.82%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ICAD vs. PHIO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ICAD iCAD, Inc.	0.00%	111.48%	3.39%	-3.28%	-74.58%	-45.45%	69.88%	110.00%	7.56%	6.34%
PHIO Phio Pharmaceuticals Corp.	6.67%	-41.67%	-73.68%	-82.97%	-62.80%	-62.83%	-71.40%	-48.17%	-94.07%	-22.21%

Correlation

The correlation between ICAD and PHIO is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.07
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.12
Correlation (10Y) Calculated over the trailing 10-year period	0.13
Correlation (All Time) Calculated using the full available price history since May 11, 2012	0.12

Fundamentals

Total Revenue (TTM) ICAD : $19.53M PHIO : $0.00
Gross Profit (TTM) ICAD : $16.77M PHIO : -$1.08M
EBITDA (TTM) ICAD : -$4.84M PHIO : -$7.23M

Return for Risk

ICAD vs. PHIO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PHIO

PHIO Risk / Return Rank: 20
PHIO Sharpe Ratio Rank: 18
PHIO Sortino Ratio Rank: 20
PHIO Omega Ratio Rank: 21
PHIO Calmar Ratio Rank: 18
PHIO Martin Ratio Rank: 22

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ICAD vs. PHIO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iCAD, Inc. (ICAD) and Phio Pharmaceuticals Corp. (PHIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	ICAD	PHIO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.53	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.36	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.46	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.25	—

Drawdowns

Drawdown Indicators

	ICAD	PHIO	Difference
Max Drawdown Largest peak-to-trough decline	—	-100.00%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-71.05%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-97.15%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-99.67%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-100.00%	—
Current Drawdown Current decline from peak	—	-100.00%	—
Average Drawdown Average peak-to-trough decline	—	-91.33%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	48.14%	—

Volatility

Volatility by Period

	ICAD	PHIO	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	11.39%	—
Volatility (6M) Calculated over the trailing 6-month period	—	64.55%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	86.33%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	183.79%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	150.20%	—

Dividends

ICAD vs. PHIO - Dividend Comparison

Neither ICAD nor PHIO has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ICAD and PHIO in my portfolio?

ICAD and PHIO have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.